Ashish Arshanapalli
MOHS-Micrographic Surgery · Mansfield, TXNPI 1639563505
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 253 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations.
Across 253 payments — averaging $22.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$1K
- Regeneron Healthcare Solutions, Inc.$666
- LEO Pharma Inc.$526
- AbbVie$439
- UCB, Inc.$351
- Sun Pharmaceutical Industries Inc.$340
- plus $2K from 20 others
What the payments were for
- Food & beverage$5,62999%
- Education$801%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 33 | $1,077 |
| Regeneron Healthcare Solutions, Inc. | 30 | $666 |
| LEO Pharma Inc. | 22 | $526 |
| AbbVie(2 entities) | 18 | $439 |
| UCB, Inc. | 17 | $351 |
| Sun Pharmaceutical Industries Inc. | 13 | $340 |
| Incyte Corporation | 16 | $319 |
| Novartis | 14 | $294 |
| Johnson & Johnson | 12 | $284 |
| Dermavant Sciences, Inc. | 19 | $273 |
| Lilly USA, LLC | 8 | $177 |
| E.r. Squibb & Sons, L.L.C. | 9 | $166 |
| Mayne Pharma Commercial LLC | 9 | $157 |
| Galderma Laboratories, L.p. | 8 | $130 |
| Biotissue Holdings Inc. | 1 | $100 |
| Boehringer Ingelheim | 4 | $82 |
| Pfizer | 5 | $71 |
| Almirall LLC | 3 | $68 |
| Organon | 3 | $36 |
| Journey Medical Corporation | 2 | $35 |
| Kerecis Limited | 2 | $34 |
| Fresenius Kabi USA, LLC | 1 | $22 |
| Amgen | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $15 |
| Biofrontera Inc. | 1 | $10 |
How this compares
$5,709 in reported general payments places this provider in the 75th percentile of 109 mohs-micrographic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 91 | $593 |
| Cefadroxil | 82 | $500 |
| Doxycycline Hyclate | 50 | $416 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Mansfield
- Aaron FarbergRockwall$1.5M
- Suneel ChilukuriBellaire$288K
- Ryan O QuinnSan Antonio$167K
- Paul FriedmanHouston$131K
- Brent SpencerFrisco$45K
- Julie CroleyThe Woodlands$30K
- Kayla McNieceBellaire$13K
- Hubert ChodkiewiczCedar Park$13K
- Meredith OrsethCedar Hill$12K
- Saira MominGrapevine$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.